SACUBITRIL; VALSARTAN | A213611 | NOVUGEN PHARMA SDN BHD
Highest NADAC/Unit
$0.5804
per ea
Lowest NADAC/Unit
$0.5020
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 82293002910SACUBITRIL-VALSARTAN 97-103 MG | $0.5804 | EA | Generic | — | 2026-10-21 |
| 82293002920SACUBITRIL-VALSARTAN 97-103 MG | $0.5804 | EA | Generic | — | 2026-10-21 |
| 82293002810SACUBITRIL-VALSARTAN 49-51 MG | $0.5427 | EA | Generic | — | 2026-10-21 |
| 82293002820SACUBITRIL-VALSARTAN 49-51 MG | $0.5427 | EA | Generic | — | 2026-10-21 |
| 82293002710SACUBITRIL-VALSARTAN 24-26 MG | $0.5020 | EA | Generic | — | 2026-10-21 |
| 82293002720SACUBITRIL-VALSARTAN 24-26 MG | $0.5020 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.